Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/14272/000114036120025818/nt10016009x5_8k.htm
March 2024
March 2024
February 2024
February 2024
January 2024
December 2023
November 2023
October 2023
August 2023
July 2023
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/14272/000114036120025818/nt10016009x5_8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Bristol Myers Squibb Co.
Bristol Myers Squibb Co's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Ticker: BMYEvents:
CIK: 14272
Form Type: 8-K Corporate News
Accession Number: 0001140361-20-025818
Submitted to the SEC: Tue Nov 17 2020 4:28:24 PM EST
Accepted by the SEC: Tue Nov 17 2020
Period: Tuesday, November 17, 2020
Industry: Pharmaceutical Preparations